Treatment of Acute Liver Failure in Mice by Immortalized Human Hepatocytes

房青,高福云,徐梅,张文健,叶丽亚,许世清,许亚平,李成辉,娄晋宁

DOI: https://doi.org/10.3969/cmba.j.issn.1673-713x.2010.04.003

2010-01-01

Abstract:Objective To evaluate the efficiency of microcarriers cultured with immortalized human hepatocytes (IHH) on treatment of acute liver failure (ALF) in animal model. Methods ALF model was established by intraperitoneal injection of CCl4 in nude mice. The microcarriers cultured with IHH were intraperitoneally injected to ALF animal for dialysis,the ALF animals treated with empty microcarriers were used as control. The efficiency of the dialysis was evaluated by plasma aminotransferase,histopathological examinations and survival rate of ALF mice. The immunohistochemical staining for α1-antitrypsin in microcarriers with IHH was performed to analyze their viability and function. Results The plasma aminotransferase was increased over 10 times in ALF mice or in ALF mice treated with empty microcarriers as compared with that in normal mice 24 hours after CCl4 administration,all mice with ALF without any treatment or treated with empty microcarriers died within 48 hours and extensive hepatocellular necrosis was demonstrated by histopathological examinations. Although the plasma aminotransferase was similar to those control groups 24 hours after CCl4 administration,the survival rate of ALF mice treated with IHH-microcarriers was 83.3% within 48 hours after CCl4 administration and maintained to long-term survival. The histopathological examinations showed that hepatocyte necrosis was significantly reduced in ALF mice treated with IHH-microcarriers as compared with controls and immunohistochemical staining indicated that IHH on microcarriers was viable and expressed α1-antitrypsin. Conclusion The intraperitoneal dialysis with microcarriers cultured with IHH is effective for ALF therapy in vivo,suggesting the IHH is suitable for cell material of bioartificial liver.